SANGAMO THERAPEUTICS INC COM USD0.01 earnings per share and revenue

0R1D earnings per share for the last quarter are -0.27 USD whereas the estimation was -0.21 USD which accounts for -26.32% surprise. Company revenue for the same period amounts to 481.00 k USD despite the estimated figure of 6.36 M USD. Estimated earnings per share for the next quarter are -0.14 USD, and revenue is expected to reach 7.71 M USD. Also watch annual changes over time to get a bigger picture of 0R1D earnings per share and revenue dynamics.